KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) FCF Margin (2016 - 2025)

Novavax (NVAX) has 16 years of FCF Margin data on record, last reported at 24.44% in Q4 2025.

  • For Q4 2025, FCF Margin rose 17103.0% year-over-year to 24.44%; the TTM value through Dec 2025 reached 23.09%, down 1014.0%, while the annual FY2025 figure was 21.77%, 882.0% down from the prior year.
  • FCF Margin reached 24.44% in Q4 2025 per NVAX's latest filing, down from 148.2% in the prior quarter.
  • Across five years, FCF Margin topped out at 148.2% in Q3 2025 and bottomed at 406.85% in Q1 2023.
  • Average FCF Margin over 5 years is 52.87%, with a median of 36.88% recorded in 2025.
  • Peak YoY movement for FCF Margin: surged 83322bps in 2021, then tumbled -39428bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 151.89% in 2021, then soared by 90bps to 15.59% in 2022, then tumbled by -301bps to 62.57% in 2023, then crashed by -212bps to 195.47% in 2024, then soared by 87bps to 24.44% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 24.44% in Q4 2025, 148.2% in Q3 2025, and 72.88% in Q2 2025.